1. 1Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada
2. 2Current affiliation: Amphista Therapeutics, Cambridge, United Kingdom
3. 3Princess Margaret Cancer Centre and Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada
4. 4Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; email: d.barsyte@utoronto.ca